Prospective comparison of five mediators of the systemic response after high-intensity focused ultrasound and targeted cryoablation for localized prostate cancer

BJU International

Volumn 104, Issue 8, 2009, Pages 1063-1067

  Li, Liao Yuan ^a   Yang, Ming ^a   Gao, Xin ^a   Zhang, Hai Bin ^a   Li, Jie Fang ^b   Xu, Wen Feng ^a   Lin, Zhe ^a   Zhou, Xie Lai ^c  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF SOUTH CHINA   (China)

^c PEOPLE S HOSPITAL OF HANGZHOU MEDICAL COLLEGE   (China)

Author keywords

Acute phase reaction; Cryoablation; High intensity focused ultrasound; Prostate cancer; Tissue trauma

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; SERUM AMYLOID A; TUMOR NECROSIS FACTOR ALPHA;

ACUTE PHASE RESPONSE; ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CRYOABLATION; HIGH INTENSITY FOCUSED ULTRASOUND; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE SURGERY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE CANCER; QUANTITATIVE ANALYSIS; TISSUE INJURY;

ACUTE-PHASE REACTION; AGED; C-REACTIVE PROTEIN; CRYOSURGERY; EPIDEMIOLOGIC METHODS; HUMANS; INTERLEUKIN-10; INTERLEUKIN-6; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; SERUM AMYLOID A PROTEIN; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA; ULTRASOUND, HIGH-INTENSITY FOCUSED, TRANSRECTAL;

EID: 70349246816     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08481.x     Document Type: Article

References (26)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2007. Cancer J Clin 2007 57 : 43 6
2. Grubb RL, Vardi IY, Bhayani SB, Kibel AS. Minimally invasive approaches to localized prostate carcinoma. Hematol Oncol Clin North Am 2006 20 : 879 895
3. Haar GT, Coussios C. High intensity focused ultrasound: physical principles and devices. Int J Hyperthermia 2007 23 : 89 104 (Pubitemid 46404248)
4. Rebillard X, Soulié M, Chartier-Kastler E et al. High-intensity focused ultrasound in prostate cancer; a systematic literature review of the French Association of Urology. BJU Int 2008 101 : 1205 1213
5. Bonney WW, Fallon B, Gerber WL et al. Cryosurgery in prostatic cancer: elimination of local lesion. Urology 1983 22 : 8 15
6. Onik GM, Cohen JK, Reyes GD et al. Transrectal ultrasound-guided percutaneous radical cryosurgical ablation of the prostate. Cancer 1993 72 : 291 299
7. Han KR, Belldegrun AS. Third-generation cryosurgery for primary and recurrent prostate cancer. BJU Int 2004 93 : 14 8
8. Choileain NN, Redmond HP. Cell response to surgery. Arch Surg 2006 141 : 1132 1140
9. Shenkin A, Fraser WD, Series J et al. The serum interleukin-6 response to elective surgery. Lymphokine Res 1989 8 : 123 7
10. Ruzic B, Tomaskovic I, Trnski D, Kraus O, Bekavac-Beslin M, Vrkic N. Systemic stress responses in patients undergoing surgery for benign prostatic hyperplasia. BJU Int 2005 95 : 77 80
11. Uchida T, Sanghvi NT, Gardner TA et al. Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-2N0M0 localized prostate cancer: a preliminary report. Urology 2002 59 : 394 398
12. Zisman A, Pantuck AJ, Cohen JK, Belldegrun AS. Prostate cryoablation using direct transperineal placement of ultrathin probes through a 17-gauge brachytherapy template - technique and preliminary results. Urology 2001 58 : 988 993
13. Charlson ME, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994 47 : 1245 1251
14. Greene FL, Page DL, Fleming ID et al., eds. AJCC Cancer Staging Manual, 6th edn. New York : Springer-Verlag, 2002
15. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994 15 : 74 80
16. Seifert JK, Stewart GJ, Hewitt PM, Bolton EJ, Junginger T, Morris DL. Interleukin-6 and tumor necrosis factor-alpha levels following hepatic cryotherapy: association with volume and duration of freezing. World J Surg 1999 23 : 1019 1026
17. Criuickshank AM, Fraser WD, Burns HJ, Van Damme J, Shenkin A. Response of serum interleukin-6 in patients undergoing elective surgery of varying severity. Clin Sci 1990 79 : 161 165
18. Baigrie RJ, Lamont PM, Kwiatkowski D, Dallman MJ, Morris PJ. Systemic cytokine response after major surgery. Br J Surg 1992 79 : 757 760
19. Kragsbjerg P, Holmberg H, Vikerfors T. Serum concentrations of interleukin-6, tumour necrosis factor-alpha, and C-reactive protein in patients undergoing major operations. Eur J Surg 1995 161 : 17 22
20. Bellon JM, Manzano L, Larrad A, Honduvilla GN, Bujan J, Alvarez-Mon M. Endocrine and immune response to injury after open and laparoscopic cholecystectomy. Int Surg 1998 83 : 24 7
21. Aus G. Current status of HIFU and cryotherapy in prostate cancer-a review. Eur Urol 2006 50 : 927 934
22. Vallancien G, Prapotnich D, Cathelineau X, Baumert H, Rozet F. Transrectal focused ultrasound combined with transurethral resection of the prostate for the treatment of localized prostate cancer: feasibility study. J Urol 2004 171 : 2265 2267
23. Briganti A, Gallina A, Suardi N et al. A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer. BJU Int 2008 101 : 556 560
24. Oyen RH, Van Poppel HP, Ameye FE, Van de Voorde WA, Baert AL, Baert LV. Lymph node staging of localized prostatic carcinoma with CT and CT-guided fine-needle aspiration biopsy: prospective study of 285 patients. Radiology 1994 190 : 315 322
25. Gelet A, Chapelon JY, Bouvier R, Pangaud C, Lasne Y. Local control of prostate cancer by transrectal high intensity focused ultrasound therapy: preliminary results. J Urol 1999 161 : 156 162 (Pubitemid 29422311)
26. Cresswell J, Asterling S, Chaudhary M, Sheikh N, Greene D. Third-generation cryotherapy for prostate cancer in the UK: a prospective study of the early outcomes in primary and recurrent disease. BJU Int 2006 97 : 969 974